Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FDQYH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,638
Award facts
- Contract value 100% obligated
- $18,637.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for $18.6K to supply Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 3, 2025. The award, made on August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare facilities worldwide.
Photrexa is a corneal cross-linking system used in ophthalmology to treat corneal ectasia and keratoconus by strengthening corneal tissue. As a primary pharmaceutical supplier to military health facilities, DMS Pharmaceutical Group has established itself as a critical vendor in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and specialty pharmaceutical products. The firm fixed-price structure and the company's established IDC with DLA position this delivery order within the agency's broader strategy to ensure reliable access to specialized medical products across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDQYH?
SPE2DB25FDQYH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FDQYH worth?
The government has obligated $18,638 on SPE2DB25FDQYH.
Is contract SPE2DB25FDQYH an order under another contract?
Yes. SPE2DB25FDQYH is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQYH competed?
The extent of competition for SPE2DB25FDQYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award